| 887 |
Inhibition, NADH-ubiquinone oxidoreductase (complex I)
Short Name
Inhibition, NADH-ubiquinone oxidoreductase (complex I)
|
1 |
Cellular |
Nov 29, 2016 |
Oct 3, 2025 |
3 AOPs
|
| 885 |
Increase, Cancer
Short Name
Increase, Cancer
|
1 |
Tissue |
Nov 29, 2016 |
Aug 22, 2023 |
6 AOPs
|
| 881 |
Increased, Triglyceride
Short Name
Increased, Triglyceride
|
1 |
Cellular |
Nov 29, 2016 |
Sep 16, 2017 |
61: NFE2L2/FXR activation leading to hepatic steatosis
|
| 880 |
Increased, ApoB100
Short Name
Increased, ApoB100
|
1 |
Tissue |
Nov 29, 2016 |
Sep 16, 2017 |
61: NFE2L2/FXR activation leading to hepatic steatosis
|
| 879 |
Activation, MTTP
Short Name
Activation, MTTP
|
1 |
Cellular |
Nov 29, 2016 |
Sep 16, 2017 |
61: NFE2L2/FXR activation leading to hepatic steatosis
|
| 878 |
Inhibition, SREBP1c
Short Name
Inhibition, SREBP1c
|
1 |
Molecular |
Nov 29, 2016 |
Sep 16, 2017 |
61: NFE2L2/FXR activation leading to hepatic steatosis
|
| 877 |
Inhibition, organic anion transporter 1 (OAT1)
Short Name
Inhibition, organic anion transporter 1 (OAT1)
|
1 |
Molecular |
Nov 29, 2016 |
Sep 16, 2017 |
138: Organic anion transporter (OAT1) inhibition leading to renal failure and mortality
|
| 876 |
Increase, Mutations in Critical Genes
Short Name
Increase, Mutations in Critical Genes
|
1 |
Molecular |
Nov 29, 2016 |
Sep 16, 2017 |
2 AOPs
|
| 875 |
Binding of agonist, Ionotropic glutamate receptors
Short Name
Binding of agonist, Ionotropic glutamate receptors
|
1 |
Molecular |
Nov 29, 2016 |
Sep 16, 2017 |
2 AOPs
|
| 872 |
Increase, Site of Contact Nasal Tumors
Short Name
Increase, Site of Contact Nasal Tumors
|
1 |
Organ |
Nov 29, 2016 |
Sep 16, 2017 |
136: Intracellular Acidification Induced Olfactory Epithelial Injury Leading to Site of Contact Nasal Tumors
|
| 870 |
Increase, Cell Proliferation
Short Name
Increase, Cell Proliferation
|
2 |
Cellular |
Nov 29, 2016 |
Dec 10, 2024 |
9 AOPs
|
| 869 |
Increase, Respiratory or Squamous Metaplasia
Short Name
Increase, Respiratory or Squamous Metaplasia
|
1 |
Tissue |
Nov 29, 2016 |
Sep 29, 2017 |
136: Intracellular Acidification Induced Olfactory Epithelial Injury Leading to Site of Contact Nasal Tumors
|
| 868 |
Increase, Tissue Degeneration, Necrosis & Atrophy
Short Name
Increase, Tissue Degeneration, Necrosis & Atrophy
|
2 |
Tissue |
Nov 29, 2016 |
Sep 16, 2017 |
136: Intracellular Acidification Induced Olfactory Epithelial Injury Leading to Site of Contact Nasal Tumors
|
| 867 |
Decrease, Intracellular pH
Short Name
Decrease, Intracellular pH
|
1 |
Cellular |
Nov 29, 2016 |
Sep 16, 2017 |
136: Intracellular Acidification Induced Olfactory Epithelial Injury Leading to Site of Contact Nasal Tumors
|
| 864 |
Decreased, Body Weight
Short Name
Decreased, Body Weight
|
1 |
Individual |
Nov 29, 2016 |
Apr 30, 2019 |
6: Antagonist binding to PPARα leading to body-weight loss
|
| 863 |
Increased, Catabolism of Muscle Protein
Short Name
Increased, Catabolism of Muscle Protein
|
1 |
Organ |
Nov 29, 2016 |
Apr 30, 2019 |
6: Antagonist binding to PPARα leading to body-weight loss
|
| 862 |
Not Increased, Circulating Ketone Bodies
Short Name
Not Increased, Circulating Ketone Bodies
|
2 |
Tissue |
Nov 29, 2016 |
Apr 30, 2019 |
6: Antagonist binding to PPARα leading to body-weight loss
|
| 861 |
Decreased, Ketogenesis (production of ketone bodies)
Short Name
Decreased, Ketogenesis (production of ketone bodies)
|
1 |
Cellular |
Nov 29, 2016 |
Apr 30, 2019 |
6: Antagonist binding to PPARα leading to body-weight loss
|
| 860 |
Decreased, Mitochondrial Fatty Acid Beta Oxidation
Short Name
Decreased, Mitochondrial Fatty Acid Beta Oxidation
|
1 |
Molecular |
Nov 29, 2016 |
Sep 16, 2017 |
318: Glucocorticoid Receptor activation leading to hepatic steatosis
|
| 859 |
Decreased, Peroxisomal Fatty Acid Beta Oxidation of Fatty Acids
Short Name
Decreased, Peroxisomal Fatty Acid Beta Oxidation of Fatty Acids
|
1 |
Molecular |
Nov 29, 2016 |
Sep 16, 2017 |
None
|
| 858 |
Decreased, PPARalpha transactivation of gene expression
Short Name
Decreased, PPARalpha transactivation of gene expression
|
1 |
Molecular |
Nov 29, 2016 |
Apr 30, 2019 |
6: Antagonist binding to PPARα leading to body-weight loss
|
| 857 |
Binding as antagonist, Antagonist binding to PPARalpha ligand binding domain
Short Name
Binding as antagonist, Antagonist binding to PPARalpha ligand binding domain
|
0 |
Molecular |
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 856 |
Formation, Hepatocellular and Bile duct tumors
Short Name
Formation, Hepatocellular and Bile duct tumors
|
2 |
Organ |
Nov 29, 2016 |
Sep 16, 2017 |
41: Sustained AhR Activation leading to Rodent Liver Tumours
|
| 854 |
Alterations, Cellular proliferation / hyperplasia
Short Name
Alterations, Cellular proliferation / hyperplasia
|
3 |
Tissue |
Nov 29, 2016 |
Sep 16, 2017 |
2 AOPs
|
| 853 |
Changes/Inhibition, Cellular Homeostasis and Apoptosis
Short Name
Changes/Inhibition, Cellular Homeostasis and Apoptosis
|
2 |
Cellular |
Nov 29, 2016 |
Sep 16, 2017 |
41: Sustained AhR Activation leading to Rodent Liver Tumours
|